dihydroxyphenylalanine has been researched along with Cancer of Pancreas in 27 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (7.41) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (33.33) | 29.6817 |
2010's | 13 (48.15) | 24.3611 |
2020's | 3 (11.11) | 2.80 |
Authors | Studies |
---|---|
Mitrofanova, LB | 1 |
Perminova, AA | 1 |
Ryzhkova, DV | 1 |
Sukhotskaya, AA | 1 |
Bairov, VG | 1 |
Nikitina, IL | 1 |
Jullien, M | 1 |
Reichert, T | 1 |
D'Anella, P | 1 |
Castinetti, F | 2 |
Barlier, A | 1 |
Brue, T | 1 |
Taieb, D | 5 |
Cuny, T | 1 |
Yang, N | 1 |
Tanner, JA | 1 |
Zheng, BJ | 1 |
Watt, RM | 1 |
He, ML | 1 |
Lu, LY | 1 |
Jiang, JQ | 1 |
Shum, KT | 1 |
Lin, YP | 1 |
Wong, KL | 1 |
Lin, MCM | 1 |
Kung, HF | 1 |
Sun, H | 1 |
Huang, JD | 1 |
Marinho, CC | 1 |
Nicolato, AJPG | 1 |
Reis, VW | 1 |
Dos Santos, RC | 1 |
Silva, JC | 1 |
Faria, HP | 1 |
Machado-Coelho, GLL | 1 |
Sun, Y | 2 |
Zhang, N | 1 |
Wang, J | 2 |
Guo, Y | 1 |
Sun, B | 1 |
Liu, W | 1 |
Zhou, H | 1 |
Yang, C | 1 |
Wei, L | 1 |
Ball, S | 1 |
Dennis, JA | 1 |
Bedanie, G | 1 |
Nugent, K | 1 |
Hayek, AJ | 1 |
Scott, V | 1 |
Yau, P | 1 |
Zolfaghari, K | 1 |
Goldwater, M | 1 |
Almquist, J | 1 |
Arroliga, AC | 1 |
Ghamande, S | 1 |
Wu, Q | 1 |
Ma, W | 1 |
Shi, R | 1 |
Zhang, B | 1 |
Mao, X | 1 |
Zheng, W | 1 |
Sbhatu, DB | 1 |
Berhe, GG | 1 |
Hndeya, AG | 1 |
Abraha, HB | 1 |
Abdu, A | 1 |
Gebru, HA | 1 |
Taye, MG | 1 |
Mulugeta, A | 1 |
Weldemichael, MY | 1 |
Tekle, HT | 1 |
Kidanemariam, HG | 1 |
Surger, M | 1 |
Angelov, A | 1 |
Liebl, W | 1 |
Hookey, L | 1 |
Bertiger, G | 1 |
Johnson, KL | 1 |
Boules, M | 1 |
Ando, M | 1 |
Dahdal, DN | 1 |
Riedl, JM | 1 |
Posch, F | 1 |
Prager, G | 1 |
Eisterer, W | 1 |
Oehler, L | 1 |
Sliwa, T | 1 |
Wilthoner, K | 1 |
Petzer, A | 1 |
Pichler, P | 1 |
Hubmann, E | 1 |
Winder, T | 1 |
Burgstaller, S | 1 |
Korger, M | 1 |
Andel, J | 1 |
Greil, R | 1 |
Neumann, HJ | 1 |
Pecherstorfer, M | 1 |
Philipp-Abbrederis, K | 1 |
Djanani, A | 1 |
Gruenberger, B | 1 |
Laengle, F | 1 |
Wöll, E | 1 |
Gerger, A | 1 |
Evans, WE | 1 |
Raynor, HA | 1 |
Howie, W | 1 |
Lipton, RB | 1 |
Thomas, GJ | 1 |
Wing, RR | 1 |
Pavlovic, J | 1 |
Farris, SG | 1 |
Bond, DS | 1 |
Hepprich, M | 1 |
Antwi, K | 1 |
Waser, B | 1 |
Reubi, JC | 1 |
Wild, D | 1 |
Christ, ER | 1 |
Braüner Christensen, J | 1 |
Aasbrenn, M | 1 |
Sandoval Castillo, L | 1 |
Ekmann, A | 1 |
Giver Jensen, T | 1 |
Pressel, E | 1 |
Haxholdt Lunn, T | 1 |
Suetta, C | 1 |
Palm, H | 1 |
Mansour, FA | 1 |
Al-Mazrou, A | 1 |
Al-Mohanna, F | 1 |
Al-Alwan, M | 1 |
Ghebeh, H | 1 |
Brown-Johnson, C | 1 |
Safaeinili, N | 1 |
Zionts, D | 1 |
Holdsworth, LM | 1 |
Shaw, JG | 1 |
Asch, SM | 1 |
Mahoney, M | 1 |
Winget, M | 1 |
Luo, Y | 1 |
Shan, H | 1 |
Gao, X | 1 |
Qi, P | 1 |
Li, Y | 2 |
Li, B | 1 |
Rong, X | 1 |
Shen, B | 1 |
Zhang, H | 1 |
Lin, F | 1 |
Tang, Z | 1 |
Fang, Z | 1 |
Peng, Z | 1 |
Jimenez, JL | 1 |
Ayer, GB | 1 |
Klepov, VV | 1 |
Pace, KA | 1 |
Zur Loye, HC | 1 |
Acquaroni, M | 1 |
Svartz, G | 1 |
Pérez Coll, C | 1 |
Otludil, B | 1 |
Ayaz, S | 1 |
Hill, A | 1 |
Elakkad, A | 1 |
Kuban, J | 1 |
Sabir, S | 1 |
Odisio, B | 1 |
Huang, SY | 1 |
Mahvash, A | 1 |
Miller, E | 1 |
Kroll, MH | 1 |
Overman, M | 1 |
Tam, AL | 1 |
Gupta, S | 1 |
Sheth, RA | 1 |
Deandreis, D | 1 |
Guarneri, A | 1 |
Ceci, F | 1 |
Lillaz, B | 1 |
Bartoncini, S | 1 |
Oderda, M | 1 |
Nicolotti, DG | 1 |
Pilati, E | 1 |
Passera, R | 1 |
Zitella, A | 1 |
Bellò, M | 1 |
Parise, R | 1 |
Carlevato, R | 1 |
Ricardi, U | 1 |
Gontero, P | 1 |
Coyne, GO' | 1 |
Wang, L | 2 |
Zlott, J | 1 |
Juwara, L | 1 |
Covey, JM | 1 |
Beumer, JH | 1 |
Cristea, MC | 1 |
Newman, EM | 1 |
Koehler, S | 1 |
Nieva, JJ | 1 |
Garcia, AA | 1 |
Gandara, DR | 1 |
Miller, B | 1 |
Khin, S | 1 |
Miller, SB | 1 |
Steinberg, SM | 1 |
Rubinstein, L | 1 |
Parchment, RE | 1 |
Kinders, RJ | 1 |
Piekarz, RL | 1 |
Kummar, S | 1 |
Chen, AP | 1 |
Doroshow, JH | 1 |
Li, X | 2 |
Chen, J | 2 |
Gan, L | 1 |
Tian, Y | 1 |
Shi, B | 1 |
Yang, Y | 1 |
Li, G | 1 |
Wu, D | 1 |
Wen, A | 1 |
Wu, Y | 1 |
Zhou, X | 1 |
Koyappayil, A | 1 |
Chavan, SG | 1 |
Mohammadniaei, M | 1 |
Go, A | 1 |
Hwang, SY | 1 |
Lee, MH | 1 |
Kurokawa, Y | 1 |
Yamashita, K | 1 |
Kawabata, R | 1 |
Fujita, J | 1 |
Imamura, H | 1 |
Takeno, A | 1 |
Takahashi, T | 1 |
Yamasaki, M | 1 |
Eguchi, H | 1 |
Doki, Y | 1 |
Schulte, T | 1 |
Sala, BM | 1 |
Nilvebrant, J | 1 |
Nygren, PÅ | 1 |
Achour, A | 1 |
Shernyukov, A | 1 |
Agback, T | 1 |
Agback, P | 1 |
Karami, H | 1 |
Shariatifar, N | 1 |
Nazmara, S | 1 |
Moazzen, M | 1 |
Mahmoodi, B | 1 |
Mousavi Khaneghah, A | 1 |
Sinha, N | 1 |
Mukhopadhyay, S | 1 |
Sau, M | 1 |
Qi, Y | 1 |
Wan, M | 1 |
Abd El-Aty, AM | 1 |
Li, H | 2 |
Cao, L | 1 |
She, Y | 1 |
Shao, Y | 1 |
Jin, F | 1 |
Wang, S | 1 |
Melendez-Araújo, MS | 1 |
Lemos, KGE | 1 |
Arruda, SLM | 1 |
Dutra, ES | 1 |
de Carvalho, KMB | 1 |
de la Plaza Llamas, R | 1 |
Díaz Candelas, DA | 1 |
Ramia, JM | 1 |
Zhu, S | 1 |
Liu, Z | 1 |
Lu, J | 2 |
Xiang, Z | 1 |
Lan, J | 1 |
Liu, J | 1 |
Yu, M | 1 |
Chen, Y | 2 |
Sirajudeen, AAO | 1 |
Annuar, MSM | 1 |
Subramaniam, R | 1 |
Somme, F | 1 |
Montaz-Rosset, MS | 1 |
Averous, G | 2 |
Deur, J | 1 |
Goichot, B | 2 |
Bachellier, P | 4 |
Addeo, P | 2 |
Imperiale, A | 5 |
Xu, L | 1 |
Li, Z | 2 |
Song, S | 1 |
Chen, Q | 1 |
Mo, L | 1 |
Wang, C | 1 |
Fan, W | 1 |
Yan, Y | 1 |
Tong, X | 1 |
Yan, H | 1 |
Singh, A | 1 |
Chen, HC | 1 |
Chen, YF | 1 |
Lu, YJ | 1 |
Wong, KT | 1 |
Chu, CW | 1 |
Banijamali, AR | 1 |
Carvalho, AE | 1 |
Wakefield, JD | 1 |
Germano, P | 1 |
Barden, TC | 1 |
Tobin, JV | 1 |
Zimmer, DP | 1 |
Masferrer, JL | 1 |
Profy, AT | 1 |
Currie, MG | 1 |
Todd Milne, G | 1 |
Zhang, Y | 1 |
Yang, H | 1 |
Dang, Z | 1 |
Zhan, S | 1 |
Sun, C | 1 |
Hu, G | 1 |
Lin, Y | 1 |
Yuan, Q | 1 |
Karayağiz Muslu, G | 1 |
Özdemir, M | 1 |
Del Prete, S | 1 |
Nocentini, A | 1 |
Supuran, CT | 1 |
Capasso, C | 1 |
Chagas, ATA | 1 |
Ludwig, S | 1 |
Pimentel, JDSM | 1 |
de Abreu, NL | 1 |
Nunez-Rodriguez, DL | 1 |
Leal, HG | 1 |
Kalapothakis, E | 1 |
Zhang, J | 1 |
Lin, L | 1 |
Dodig, D | 1 |
Kovačić, S | 1 |
Matana Kaštelan, Z | 1 |
Žuža, I | 1 |
Benić, F | 1 |
Slaven, J | 1 |
Miletić, D | 1 |
Rumboldt, Z | 1 |
Fernandez-Botran, R | 1 |
Wellmann, IA | 1 |
Une, C | 1 |
Méndez-Chacón, E | 1 |
Hernández de Rodas, E | 1 |
Bhandari, B | 1 |
Villagrán de Tercero, CI | 1 |
Nguyen, HTT | 1 |
Romano, F | 1 |
Wampfler, R | 1 |
Mühlethaler, K | 1 |
Tannich, E | 1 |
Oberli, A | 1 |
Yang, J | 1 |
Xiang, T | 1 |
Dai, L | 1 |
Zhao, X | 1 |
Ma, L | 1 |
Zuo, D | 1 |
Wei, B | 1 |
Sui, Y | 1 |
Xu, F | 1 |
Zheng, H | 1 |
Qiu, C | 1 |
Jin, H | 1 |
Kerwin, J | 1 |
Khan, I | 1 |
Rajasekhar, B | 1 |
Venkateshwaran, U | 1 |
Durairaj, N | 1 |
Divyapriya, G | 1 |
Nambi, IM | 1 |
Joseph, A | 1 |
Aliste, M | 1 |
Garrido, I | 1 |
Flores, P | 1 |
Hellín, P | 1 |
Vela, N | 1 |
Navarro, S | 1 |
Fenoll, J | 1 |
Ansquer, C | 1 |
Touchefeu, Y | 1 |
Faivre-Chauvet, A | 1 |
Leux, C | 1 |
Le Bras, M | 1 |
Régenet, N | 1 |
Fleury, V | 1 |
Maucherat, B | 1 |
Senellart, H | 1 |
Guyetant, S | 1 |
Carlier, T | 1 |
Scotet-Cérato, E | 1 |
Rauscher, A | 1 |
Frampas, E | 1 |
Kraeber-Bodéré, F | 1 |
Berends, AMA | 1 |
Kerstens, MN | 1 |
Bolt, JW | 1 |
Links, TP | 1 |
Korpershoek, E | 1 |
de Krijger, RR | 1 |
Walenkamp, AME | 1 |
Noordzij, W | 1 |
van Etten, B | 1 |
Kats-Ugurlu, G | 1 |
Brouwers, AH | 3 |
van der Horst-Schrivers, ANA | 1 |
Cuccurullo, V | 1 |
Di Stasio, GD | 1 |
Mansi, L | 1 |
Sood, A | 1 |
Basher, RK | 1 |
Kang, M | 1 |
Shukla, J | 1 |
Behera, A | 1 |
Walia, R | 1 |
Nada, R | 1 |
Mittal, BR | 1 |
Bhattacharya, A | 1 |
Namer, IJ | 4 |
Legmann, P | 1 |
Prat, F | 1 |
Chevallier, P | 1 |
Tenenbaum, F | 1 |
Minn, H | 2 |
Kemppainen, J | 1 |
Kauhanen, S | 3 |
Forsback, S | 1 |
Seppänen, M | 3 |
Sebag, F | 2 |
Vix, M | 1 |
Kessler, L | 2 |
Moreau, F | 1 |
Guillet, B | 1 |
Mundler, O | 2 |
Bahougne, T | 1 |
Shamim, SA | 1 |
Kumar, A | 1 |
Kumar, R | 1 |
Detour, J | 1 |
Pierre, A | 1 |
Boisson, F | 1 |
Kreutter, G | 1 |
Lavaux, T | 1 |
Brasse, D | 1 |
Marchand, P | 1 |
Nuutila, P | 2 |
Tessonnier, L | 1 |
Ghander, C | 1 |
De Micco, C | 1 |
Reynaud, R | 1 |
Palazzo, FF | 1 |
Conte-Devolx, B | 1 |
Henry, JF | 1 |
Buck, AK | 1 |
Herrmann, K | 1 |
Eckel, F | 1 |
Beer, AJ | 1 |
Weisbrod, AB | 1 |
Kitano, M | 1 |
Gesuwan, K | 1 |
Millo, C | 1 |
Herscovitch, P | 1 |
Nilubol, N | 1 |
Linehan, WM | 1 |
Kebebew, E | 1 |
Jager, PL | 3 |
Koopmans, KP | 3 |
de Vries, EG | 2 |
Gullichsen, R | 1 |
Salonen, A | 1 |
Alanen, K | 1 |
Parkkola, R | 1 |
Solin, O | 1 |
Bergman, J | 1 |
Sane, T | 1 |
Salmi, J | 1 |
Välimäki, M | 1 |
Hardy, OT | 1 |
Hernandez-Pampaloni, M | 1 |
Saffer, JR | 1 |
Scheuermann, JS | 1 |
Ernst, LM | 1 |
Freifelder, R | 1 |
Zhuang, H | 1 |
MacMullen, C | 1 |
Becker, S | 1 |
Adzick, NS | 1 |
Divgi, C | 1 |
Alavi, A | 1 |
Stanley, CA | 1 |
Kapoor, RR | 1 |
Gilbert, C | 1 |
Mohnike, K | 1 |
Blankenstein, O | 1 |
Fuechtner, F | 1 |
Hussain, K | 1 |
Chirakal, R | 1 |
Marriott, CJ | 1 |
Gulenchyn, KY | 1 |
Neels, OC | 1 |
Kema, IP | 1 |
Elsinga, PH | 1 |
Sluiter, WJ | 1 |
Vanghillewe, K | 1 |
Ambrosini, V | 1 |
Tomassetti, P | 1 |
Castellucci, P | 1 |
Campana, D | 1 |
Montini, G | 1 |
Rubello, D | 1 |
Nanni, C | 1 |
Rizzello, A | 1 |
Franchi, R | 1 |
Fanti, S | 1 |
Käser, H | 1 |
Wagner, HP | 1 |
Zuppinger, K | 1 |
Zurbrügg, R | 1 |
Delacretaz, J | 1 |
Emch, M | 1 |
Schellhorn, JP | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Localization of Focal Forms of Hyperinsulinism of Infancy With 18F-labeled L-fluoro-DOPA PET Scan[NCT00674440] | Phase 2 | 106 participants (Actual) | Interventional | 2004-12-31 | Completed | ||
The Use of Fluorodopa F 18 Positron Emission Tomography Combined With Computed Tomography in Congenital Hyperinsulinism and Insulinoma[NCT02021604] | Phase 1 | 250 participants (Anticipated) | Interventional | 2013-10-09 | Recruiting | ||
A Phase II Safety and Efficacy Study of 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Children With Hyperinsulinemic Hypoglycemia[NCT01468454] | Phase 2 | 130 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Number of Participants with Adverse Events (NCT00674440)
Timeframe: 72 hours maximum or prior to pancreatic surgery
Intervention | Participants (Count of Participants) |
---|---|
All Subjects Who Had PET | 0 |
Comparison of PET scan results with outcome of surgery and histopathology results confirmed as focal or diffuse (NCT00674440)
Timeframe: up to 1 month post surgical intervention
Intervention | Participants (Count of Participants) | |||
---|---|---|---|---|
True Negatives (PET diffuse/surgery diffuse) | False negatives (PET diffuse/surgery focal): | False positives (PET focal/surgery diffuse): | True positives (PET focal/surgery focal): | |
Subjects Who Had PET and Surgery | 40 | 6 | 3 | 46 |
"To further evaluate the safety of 18-labeled L-fluorodeoxyphenylalanine (18F-DOPA) PET/CT imaging in infants and children with congenital hyperinsulinism~- subjects are monitored clinically for any signs or symptoms of adverse events for 72 hours post PET. Adverse events are documented and followed to resolution" (NCT01468454)
Timeframe: evaluated with 72 hours or prior to pancreatic surgery (if any)
Intervention | Participants (Count of Participants) |
---|---|
(18F-DOPA) PET/CT Imaging | 0 |
To determine the sensitivity and specificity of 18F-DOPA PET/CT for the detection of a focal pancreatic lesion in infants and children with poorly controlled hyperinsulinemic hypoglycemia. (NCT01468454)
Timeframe: Surgery typically occured within a week post PET
Intervention | cases (Number) | |||
---|---|---|---|---|
True Negatives (PET diffuse/surgery diffuse) | False negatives (PET diffuse/surgery focal): | False positives (PET focal/surgery diffuse): | True positives (PET focal/surgery focal): | |
PET/CT Imaging vs Surgical Result | 34 | 10 | 4 | 52 |
4 reviews available for dihydroxyphenylalanine and Cancer of Pancreas
Article | Year |
---|---|
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours.
Topics: Animals; Dihydroxyphenylalanine; Dimerization; Edetic Acid; Fluorodeoxyglucose F18; Glucagon-Like Pe | 2019 |
18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Intestinal Neopl | 2014 |
PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes.
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gast | 2015 |
6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications.
Topics: Adenoma, Islet Cell; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Neuroendocrine Tumors; Pancrea | 2008 |
1 trial available for dihydroxyphenylalanine and Cancer of Pancreas
22 other studies available for dihydroxyphenylalanine and Cancer of Pancreas
Article | Year |
---|---|
Differential Morphological Diagnosis of Various Forms of Congenital Hyperinsulinism in Children.
Topics: Adenoma; Adenoma, Islet Cell; Congenital Hyperinsulinism; Diagnosis, Differential; Dihydroxyphenylal | 2021 |
Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient.
Topics: Dihydroxyphenylalanine; Female; Humans; Middle Aged; Multiple Endocrine Neoplasia Type 1; Neuroendoc | 2020 |
Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine Tumors.
Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Humans; Intestinal Neoplasms; Male; | 2021 |
False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET (
Topics: Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; False Positive Reactions; Female; Huma | 2018 |
68Ga-DOTA-Exendin PET-MRI Fusion Imaging in a Case of Insulinoma.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Insulinoma; Magnetic Resonance Imaging; Multimodal Im | 2019 |
Solid pseudopapillary pancreatic tumor mimicking a neuroendocrine neoplasm on ¹⁸F-FDOPA PET/CT.
Topics: Adult; Carbidopa; Diagnosis, Differential; Dihydroxyphenylalanine; Dopamine Agents; Fluorine Radiois | 2013 |
Topographic diagnosis: respective roles of morphological and functional imaging.
Topics: 5-Hydroxytryptophan; Anatomy, Cross-Sectional; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeo | 2013 |
18F-FDOPA PET/CT imaging of insulinoma revisited.
Topics: Adult; Aged; Aged, 80 and over; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Hyperinsulinism; | 2015 |
Dynamic 18F-FDOPA PET Findings After Carbidopa Premedication in 2 Adult Patients With Insulinoma-Related Hyperinsulinemic Hypoglycemia.
Topics: Adult; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Hyperinsulinism; Hypoglycemia; Insulinoma; | 2015 |
Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging.
Topics: Animals; Carbidopa; Cell Line, Tumor; Dihydroxyphenylalanine; Female; Image Enhancement; Insulinoma; | 2017 |
Premedication with carbidopa masks positive finding of insulinoma and beta-cell hyperplasia in [(18)F]-dihydroxy-phenyl-alanine positron emission tomography.
Topics: Carbidopa; Diagnostic Errors; Dihydroxyphenylalanine; Enzyme Inhibitors; Fluorine Radioisotopes; Hum | 2008 |
Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia.
Topics: Adolescent; Adult; Aged; Child; Dihydroxyphenylalanine; Female; Humans; Hyperinsulinism; Hypoglycemi | 2010 |
Pancreatic and hepatobiliary cancers.
Topics: Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; | 2011 |
Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome.
Topics: Adult; Central Nervous System Neoplasms; Cohort Studies; Contrast Media; Dihydroxyphenylalanine; Fem | 2012 |
[Gastroenteropancreatic neuroendocrine tumours (carcinoid tumours): definition, clinical aspects, diagnosis and therapy].
Topics: Carcinoid Tumor; Dihydroxyphenylalanine; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; P | 2006 |
Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Hyperplasia; Insulin-Secreting Cells; Insulinoma; Mal | 2007 |
Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
Topics: Biopsy; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Image Interpretation, Computer-Assisted; In | 2007 |
Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
Topics: Biopsy; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Image Interpretation, Computer-Assisted; In | 2007 |
Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
Topics: Biopsy; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Image Interpretation, Computer-Assisted; In | 2007 |
Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
Topics: Biopsy; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Image Interpretation, Computer-Assisted; In | 2007 |
Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
Topics: Biopsy; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Image Interpretation, Computer-Assisted; In | 2007 |
Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
Topics: Biopsy; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Image Interpretation, Computer-Assisted; In | 2007 |
Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
Topics: Biopsy; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Image Interpretation, Computer-Assisted; In | 2007 |
Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
Topics: Biopsy; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Image Interpretation, Computer-Assisted; In | 2007 |
Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
Topics: Biopsy; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Image Interpretation, Computer-Assisted; In | 2007 |
Congenital hyperinsulinism: [18F]DOPA PET/CT scan of a focal lesion in the head of the pancreas.
Topics: Dihydroxyphenylalanine; Dopamine Agents; Humans; Hyperinsulinism; Image Interpretation, Computer-Ass | 2008 |
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
Topics: 5-Hydroxytryptophan; Adenoma, Islet Cell; Adult; Aged; Carbon Radioisotopes; Carcinoid Tumor; Dihydr | 2008 |
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours.
Topics: Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Gastrointestinal Neoplasms; Humans; Lung Ne | 2008 |
[Biochemical tumor diagnosis in childhood].
Topics: Adenoma, Islet Cell; Adrenal Gland Neoplasms; Carcinoma, Hepatocellular; Child; Cushing Syndrome; De | 1974 |
[Distribution of DL-3 (3,4-dihydroxyphenyl)-alanine-2 C14 in the organism of mice with Cloudmann's S91 melanoma].
Topics: Adrenal Gland Neoplasms; Animals; Carbon Isotopes; Computers; Dihydroxyphenylalanine; Isocarboxazid; | 1970 |